AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
A dose-ranging study to evaluate the antiretroviral activity and safety ofamprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience
Authors: Schooley, RT Clumeck, N Haubrich, R Thompson, M Danner, SA van Der Ende, ME Sereni, D Antunes, F Blake, D Myers, RE Tisdale, M Millard, J Mustafa, N Nacci, P
Citation: Rt. Schooley et al., A dose-ranging study to evaluate the antiretroviral activity and safety ofamprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience, ANTIVIR TH, 6(2), 2001, pp. 89-96
No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection
Authors: Lauw, FN van der Meer, JTM de Metz, J Danner, SA van der Poll, T
Citation: Fn. Lauw et al., No beneficial effect of interferon-gamma treatment in 2 human immunodeficiency virus-infected patients with Mycobacterium avium complex infection, CLIN INF D, 32(4), 2001, pp. E81-E82
Selection by AZT and rapid replacement in the absence of drugs of HIV type1 resistant to multiple nucleoside analogs
Authors: Lukashov, VV Huismans, R Jebbink, MF Danner, SA De Boer, RJ Goudsmit, J
Citation: Vv. Lukashov et al., Selection by AZT and rapid replacement in the absence of drugs of HIV type1 resistant to multiple nucleoside analogs, AIDS RES H, 17(9), 2001, pp. 807-818
Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses
Authors: Notermans, DW De Jong, JJ Goudsmit, J Bakker, MR Roos, MTL Nijholt, L Cremers, J Hellings, JA Danner, SA De Ronde, A
Citation: Dw. Notermans et al., Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses, AIDS RES H, 17(11), 2001, pp. 1003-1008
T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy
Authors: Kostense, S Raaphorst, FM Joling, J Notermans, DW Prins, JM Danner, SA Reiss, P Lange, JMA Teale, JM Miedema, F
Citation: S. Kostense et al., T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy, AIDS, 15(9), 2001, pp. 1097-1107
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection
Authors: van der Valk, M Gisolf, EH Reiss, P Wit, FWNM Japour, A Weverling, GJ Danner, SA
Citation: M. Van Der Valk et al., Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection, AIDS, 15(7), 2001, pp. 847-855
Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection
Authors: Nieuwkerk, PT Gisolf, EH Reijers, MHE Lange, JMA Danner, SA Sprangers, MAG
Citation: Pt. Nieuwkerk et al., Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection, AIDS, 15(15), 2001, pp. 1985-1991
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study
Authors: Nieuwkerk, PT Sprangers, MAG Burger, DM Hoetelmans, RMW Hugen, PWH Danner, SA van der Ende, ME Schneider, MME Schrey, G Meenhorst, PL Sprenger, HG Kauffmann, RH Jambroes, M Chesney, MA de Wolf, F Lange, JMA
Citation: Pt. Nieuwkerk et al., Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study, ARCH IN MED, 161(16), 2001, pp. 1962-1968
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy
Authors: Gisolf, EH van Praag, RME Jurriaans, S Portegies, P Goudsmit, J Danner, SA Lange, JMA Prins, JM
Citation: Eh. Gisolf et al., Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy, J ACQ IMM D, 25(5), 2000, pp. 426-433
Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine
Authors: Gisolf, EH Dreezen, C Danner, SA Weel, JLF Weverling, GJ
Citation: Eh. Gisolf et al., Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine, CLIN INF D, 31(5), 2000, pp. 1234-1239
Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases
Authors: ter Hofstede, HJM de Marie, D Foudraine, NA Danner, SA Brinkman, K
Citation: Hjm. Ter Hofstede et al., Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases, INT J STD A, 11(9), 2000, pp. 611-616
Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations
Authors: Notermans, DW De Wolf, F Oudshoorn, P Cuijpers, HT Pirillo, M Tiller, FW McClernon, DR Prins, JM Lange, JMA Danner, SA Goudsmit, J Jurriaans, S
Citation: Dw. Notermans et al., Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations, AIDS RES H, 16(15), 2000, pp. 1507-1517
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals
Authors: van Heeswijk, RPG Veldkamp, AI Mulder, JW Meenhorst, PL Wit, FWNM Lange, JMA Danner, SA Foudraine, NA Kwakkelstein, MO Reiss, P Beijnen, JH Hoetelmans, RMW
Citation: Rpg. Van Heeswijk et al., The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals, AIDS, 14(8), 2000, pp. F77-F82
Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir
Authors: Gisolf, EH van Heeswijk, RPG Hoetelmans, RWM Danner, SA
Citation: Eh. Gisolf et al., Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir, AIDS, 14(7), 2000, pp. 801-805
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine
Authors: Gisolf, EH Jurriaans, S Pelgrom, J van Wanzeele, F van der Ende, ME Brinkman, K Borst, MJ de Wolf, F Japour, AJ Danner, SA
Citation: Eh. Gisolf et al., The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine, AIDS, 14(4), 2000, pp. 405-413
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy
Authors: Nieuwkerk, PT Gisolf, EH Colebunders, R Wu, AW Danner, SA Sprangers, MA
Citation: Pt. Nieuwkerk et al., Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy, AIDS, 14(2), 2000, pp. 181-187
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
Authors: den Brinker, M Wit, FWNM Wertheim-van Dillen, PME Jurriaans, S Weel, J van Leeuwen, R Pakker, NG Reiss, P Danner, SA Weverling, GJ Lange, JMA
Citation: M. Den Brinker et al., Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection, AIDS, 14(18), 2000, pp. 2895-2902
Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine
Authors: Gisolf, EH Enting, RH Jurriaans, S de Wolf, F van der Ende, ME Hoetelmans, RMW Portegies, P Danner, SA
Citation: Eh. Gisolf et al., Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine, AIDS, 14(11), 2000, pp. 1583-1589
Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy
Authors: Hlavacek, WS Stilianakis, NI Notermans, DW Danner, SA Perelson, AS
Citation: Ws. Hlavacek et al., Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy, P NAS US, 97(20), 2000, pp. 10966-10971
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy
Authors: Clark, DR Repping, S Pakker, NG Prins, JM Notermans, DW Wit, FWNM Reiss, P Danner, SA Coutinho, RA Lange, JMA Miedema, F
Citation: Dr. Clark et al., T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy, BLOOD, 96(1), 2000, pp. 242-249
Common health problems in HIV-infected travelers to the (sub)tropics
Authors: Simons, FMJ Cobelens, FGJ Danner, SA
Citation: Fmj. Simons et al., Common health problems in HIV-infected travelers to the (sub)tropics, J TRAVEL M, 6(2), 1999, pp. 71-75
Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs
Authors: de Jong, JJ Goudsmit, J Lukashov, VV Hillebrand, ME Baan, E Huismans, R Danner, SA ten Veen, JH de Wolf, F Jurriaans, S
Citation: Jj. De Jong et al., Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs, AIDS, 13(1), 1999, pp. 75-80
Antigen-specific T-lymphocyte proliferative responses during highly activeantiretroviral therapy (HAART) of HIV-1 infection
Authors: Pontesilli, O Kerkhof-Garde, S Pakker, NG Notermans, DW Roos, MTL Klein, MR Danner, SA Miedema, F
Citation: O. Pontesilli et al., Antigen-specific T-lymphocyte proliferative responses during highly activeantiretroviral therapy (HAART) of HIV-1 infection, IMMUNOL LET, 66(1-3), 1999, pp. 213-217
Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells
Authors: Zhang, ZQ Schuler, T Zupancic, M Wietgrefe, S Staskus, KA Reimann, KA Reinhart, TA Rogan, M Cavert, W Miller, CJ Veazey, RS Notermans, D Little, S Danner, SA Richman, DD Havlir, D Wong, J Jordan, HL Schacker, TW Racz, P Tenner-Racz, K Letvin, NL Wolinsky, S Haase, AT
Citation: Zq. Zhang et al., Sexual transmission and propagation of SIV and HIV in resting and activated CD4(+) T cells, SCIENCE, 286(5443), 1999, pp. 1353-1357
Reversibility of the pathological changes in the follicular dendritic cellnetwork with treatment of HIV-1 infection
Authors: Zhang, ZQ Schuler, T Cavert, W Notermans, DW Gebhard, K Henry, K Havlir, DV Gunthard, HF Wong, JK Little, S Feinberg, MB Polis, MA Schrager, LK Schacker, TW Richman, DD Corey, L Danner, SA Haase, AT
Citation: Zq. Zhang et al., Reversibility of the pathological changes in the follicular dendritic cellnetwork with treatment of HIV-1 infection, P NAS US, 96(9), 1999, pp. 5169-5172
Risultati: 1-25 | 26-30